Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL532162 | 0.86 | — | — | |
| SCHEMBL20556377 | 0.79 | — | — | |
| SCHEMBL20556336 | 0.78 | — | — | |
| SCHEMBL822809 | 0.77 | — | — | |
| SCHEMBL2860921 | 0.72 | — | — | |
| SCHEMBL21467021 | 0.69 | BRD4 (0.31) | BRD4BRD2 | |
| SCHEMBL533312 | 0.68 | — | — | |
| SCHEMBL10945424 | 0.67 | CYP19A1 (0.34) | — | |
| SCHEMBL6781952 | 0.65 | BRD4 (0.40) | BRD4BRD2 | |
| SCHEMBL13516651 | 0.64 | BRD4 (0.41) | BRD4BRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180327628-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS LLC (US) | 2018-11-15 | — | — | US | claimed |
| EP-1761587-B1 | PLASTISOLS BASED ON A METHYLMETHACRYLATE COPOLYMER | EVONIK ROEHM GMBH (DE) | 2010-01-20 | — | — | EP | claimed |
| US-10876015-B2 | Coating compositions for forming toner coatings | ISP INVESTMENTS LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20180327628-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS LLC (US) | 2018-11-15 | — | — | US | disclosed |
| US-20080293854-A1 | Plastisols Based on a Methylmethacrylate Copolymer | ROEHM GMBH (DE) | 2008-11-27 | — | — | US | disclosed |
| US-6583281-B2 | Using phenothiazine | BASF AKTIENGESELLSCHAFT (DE) | 2003-06-24 | — | — | US | disclosed |
| US-6566441-B1 | Storage stability; compatibility with low-cost plasticisers; permit a relatively high binder content | ROEHM GMBH & CO KG (DE) | 2003-05-20 | — | — | US | disclosed |
| US-20020002280-A1 | Stabilized N-alkenyllactam | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-03 | — | — | US | disclosed |
| US-3939129-A | Process for the preparation of random copolymers of mono-olefins or of mono-olefins and unconjugated dienes with lactams with substitution on the nitrogen atom by an unsaturated radical | SOCIETE NATIONALE DES PETROLES D'AQUITAINE (FR) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002280-A1 | Stabilized N-alkenyllactam | ALK, NPM1, MYC | BRD4 360/4885BRD2 1222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.